thiophenes has been researched along with Cardiac Diseases in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhuva, N; Buckley, A; Harrison, M; Kelly, C; Saunders, M | 1 |
| Alexopoulos, D; Davlouros, P; Hahalis, G; Perperis, A; Siapika, A; Stavrou, K; Tsoni, E; Xanthopoulou, I | 1 |
| Balteau, M; Beauloye, C; Bertrand, L; de Meester, C; Feron, O; Ginion, A; Horman, S; Noppe, G; Porporato, PE; Roelants, V; Sakamoto, K; Sonveaux, P; Timmermans, AD; Vanoverschelde, JL; Viollet, B | 1 |
| Braun, G; Messmann, H | 1 |
| Baran, J; Kułakowski, P; Sikora-Frąc, M; Stec, S; Zaborska, B | 1 |
| Ferry, D; Fournier, M; Gebski, V; Gordon, S; Karapetis, CS; Price, TJ; Ransom, D; Simes, RJ; Tebbutt, N; Wilson, K; Yip, D | 1 |
| Fernández Guerrero, JC; Garcelán Trigo, JA; Lozano Cabezas, C; Padilla Pérez, M; Salas Bravo, D; Torres Llergo, J; Vazquez Ruiz de Castroviejo, E | 1 |
| Berghold, A; Kemperdick, B; Mergenthal, K; Petersen, JJ; Rauck, S; Roehl, I; Schulz-Rothe, S; Siebenhofer, A; Ulrich, LR | 1 |
| Cappato, R; Cohen, A; Hammerstingl, C; Kirsch, B; Lip, GY; Marin, F; Meng, IL; Morandi, E; van Eickels, M | 1 |
| Botto, GL; Colonna, P; Troccoli, R | 1 |
| Oberpichler-Schwenk, H | 1 |
| Erdem, G; Flather, MD; Geisler, T | 1 |
| Stiefelhagen, P | 1 |
| Islam, KN; Koch, WJ | 1 |
| Hammerstingl, C; Nickenig, G; Pötzsch, B | 1 |
| Collen, A; Grimbergen, J; Hanemaaijer, R; Koolwijk, P; Lupu, F; Peters, E; Quax, PH; van Hinsbergh, VW; van Lent, N | 1 |
| Erdogan, H; Fadillioglu, E; Irmak, MK; Sogut, S; Ucar, M; Yagmurca, M | 1 |
| Barst, RJ; DeMarco, T; Frost, AE; Hill, N; Horn, E; Langleben, D; McLaughlin, V; Oudiz, R; Robbins, IM; Rubenfire, M; Schilz, R; Shapiro, S; Tapson, VF; Zwicke, D | 1 |
| Akcay, A; Bayrak, R; Karanfil, A; Kaya, A; Ozkara, A; Sahin, S; Selcoki, Y; Uz, B; Uz, E | 1 |
5 review(s) available for thiophenes and Cardiac Diseases
| Article | Year |
|---|---|
Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Heart Diseases; Humans; Neoplasms; Quinazolines; Retrospective Studies; Thiophenes | 2013 |
[Gastrointestinal bleeding in cardiological patients].
Topics: Algorithms; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Drug Monitoring; Gastrointestinal Hemorrhage; Heart Diseases; Humans; Metabolic Clearance Rate; Morpholines; Phenprocoumon; Platelet Aggregation Inhibitors; Platelet Transfusion; Rivaroxaban; Thiophenes; Vitamin K | 2013 |
[Rivaroxaban. The first factor Xa inhibitor].
Topics: Animals; Factor Xa Inhibitors; Heart Diseases; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Thromboembolism; Thrombosis | 2008 |
What goes into a major acute coronary syndrome trial and what will future trials look like?
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clinical Trials as Topic; Clopidogrel; Cyclic N-Oxides; Eptifibatide; Heart Diseases; Humans; Peptides; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Research Design; Research Support as Topic; Risk Factors; Sample Size; Thiophenes; Ticagrelor; Ticlopidine; United Kingdom | 2010 |
[New study findings in cardiology. The best is the enemy of the good].
Topics: Angioplasty, Balloon, Coronary; Angiotensin II Type 2 Receptor Blockers; Anticoagulants; Atrial Fibrillation; Cardiology; Coronary Disease; Drug-Eluting Stents; Heart Diseases; Humans; Morpholines; Myocardial Infarction; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K | 2010 |
2 trial(s) available for thiophenes and Cardiac Diseases
| Article | Year |
|---|---|
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry prov
Topics: Administration, Oral; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Electric Countershock; Factor Xa Inhibitors; Female; Heart Diseases; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Rivaroxaban; Thiophenes; Thrombosis; Treatment Outcome | 2015 |
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect.
Topics: Double-Blind Method; Endothelin Receptor Antagonists; Endpoint Determination; Exercise Test; Heart Diseases; Humans; Hypertension, Pulmonary; Isoxazoles; Research Design; Thiophenes; Walking | 2005 |
12 other study(ies) available for thiophenes and Cardiac Diseases
| Article | Year |
|---|---|
Factors affecting residual platelet aggregation in prasugrel treated patients.
Topics: Acute Coronary Syndrome; Aged; Blood Platelets; Cohort Studies; Drug Resistance; Female; Heart Diseases; Hemorrhage; Humans; Maintenance Chemotherapy; Male; Middle Aged; Models, Biological; Myocardial Ischemia; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Smoking; Thiophenes | 2013 |
Role of AMP-activated protein kinase in regulating hypoxic survival and proliferation of mesenchymal stem cells.
Topics: AMP-Activated Protein Kinases; Animals; Biphenyl Compounds; Cell Proliferation; Cell Survival; Cell- and Tissue-Based Therapy; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Elongation Factor 2 Kinase; Enzyme Activation; Heart Diseases; Hypoxia; Isoenzymes; Mesenchymal Stem Cells; Mice; Mitochondrial Turnover; Myocytes, Cardiac; p21-Activated Kinases; Pyrones; Ribosomal Protein S6 Kinases, 70-kDa; Thiophenes | 2014 |
Lysis of thrombus located in the left atrial appendage. Is it the right time for a Xa factor inhibitor?
Topics: Aged; Anticoagulants; Atrial Appendage; Factor Xa Inhibitors; Female; Heart Diseases; Humans; Morpholines; Rivaroxaban; Thiophenes; Thrombosis; Tomography, X-Ray Computed; Vitamin K | 2013 |
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Substitution; Fluorouracil; Heart Diseases; Humans; Irinotecan; Middle Aged; Quinazolines; Thiophenes | 2014 |
Resolution of left ventricular thrombus by rivaroxaban.
Topics: Aged; Dose-Response Relationship, Drug; Echocardiography; Factor Xa Inhibitors; Follow-Up Studies; Heart Diseases; Heart Ventricles; Humans; Male; Morpholines; Rivaroxaban; Thiophenes; Thrombosis | 2014 |
Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Family Practice; Female; Germany; Guideline Adherence; Heart Diseases; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Mass Screening; Middle Aged; Morpholines; Practice Guidelines as Topic; Process Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Thrombosis; Venous Thromboembolism | 2014 |
[The X-VeRT study].
Topics: Adult; Aged; Anticoagulants; Atrial Fibrillation; Electric Countershock; Embolism; Factor Xa Inhibitors; Heart Diseases; Hemorrhage; Humans; International Normalized Ratio; Middle Aged; Morpholines; Multicenter Studies as Topic; Myocardial Infarction; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Risk; Rivaroxaban; Stroke; Thiophenes; Thrombophilia; Time Factors; Treatment Outcome; Vitamin K; Warfarin | 2015 |
Involvement of nuclear factor κB (NF-κB) signaling pathway in regulation of cardiac G protein-coupled receptor kinase 5 (GRK5) expression.
Topics: Acetylcysteine; Animals; G-Protein-Coupled Receptor Kinase 5; Gene Expression Regulation, Enzymologic; Heart Diseases; Myocytes, Cardiac; NF-kappa B p50 Subunit; Primary Cell Culture; Promoter Regions, Genetic; Rats; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Tetradecanoylphorbol Acetate; Thiophenes; Transcription Factor RelA | 2012 |
Resolution of giant left atrial appendage thrombus with rivaroxaban.
Topics: Anticoagulants; Atrial Appendage; Echocardiography, Three-Dimensional; Echocardiography, Transesophageal; Heart Diseases; Humans; Male; Middle Aged; Morpholines; Rivaroxaban; Thiophenes; Thrombosis; Treatment Outcome | 2013 |
Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Topics: Adenoviridae; Aprotinin; Cells, Cultured; Collagen; Culture Media; Defective Viruses; Drug Synergism; Endothelial Growth Factors; Endothelium, Vascular; Fibrin; Fibroblast Growth Factor 2; Genetic Vectors; Heart Diseases; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phenylalanine; Protease Inhibitors; Thiophenes; Thrombosis; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-3; Transduction, Genetic; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Erdosteine prevents doxorubicin-induced cardiotoxicity in rats.
Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Blood Pressure; Body Weight; Creatine Kinase; Doxorubicin; Drug Administration Schedule; Heart Diseases; Heart Rate; Humans; Injections, Intraperitoneal; L-Lactate Dehydrogenase; Male; Myocardium; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Thioglycolates; Thiophenes; Turkey | 2003 |
The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Topics: Animals; Catalase; Chemoprevention; Cyclosporine; Disease Models, Animal; Expectorants; Fibrosis; Glutathione Peroxidase; Heart; Heart Diseases; Immunosuppressive Agents; Male; Malondialdehyde; Myocardium; Nitric Oxide; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase; Thioglycolates; Thiophenes | 2007 |